Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Cerenome, Inc.

NASDAQ: CNSY · Industrial Applications and Services · 6 alerts · CIK 1095981

Share price
$0.7148Close, Nov 16
Market cap
$6.99M
Shares outstanding
9.78MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Surgical & Medical Instruments & ApparatusSIC 3841

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Cerenome, Inc. filings on SEC EDGAR ↗

7:45 AM ET 8-K
Clinical Trial Data

Cerenome Clinical Trial Data

Cerenome reported interim data from its Phase 1 ReSPECT-LM study evaluating repeat dosing of REYOBIQ in patients with leptomeningeal metastases. The data showed no dose-limiting toxicities in the first 10 patients and indicated consistent radiation delivery across repeat administrations, with early disease control signals showing no progression in evaluable patients at the six-month landmark.

Counterparty
Society for Neuro-Oncology

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.